PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 183 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $886,000 | +38.7% | 22,599 | -16.5% | 0.29% | +146.2% |
| Q2 2016 | $639,000 | +29.4% | 27,071 | +11.7% | 0.12% | +64.8% |
| Q1 2016 | $494,000 | -65.1% | 24,237 | -51.5% | 0.07% | -47.4% |
| Q4 2014 | $1,416,000 | +398.6% | 50,016 | +345.3% | 0.14% | +440.0% |
| Q3 2014 | $284,000 | -87.4% | 11,232 | -85.4% | 0.02% | -85.9% |
| Q2 2014 | $2,249,000 | +108.8% | 77,071 | +85.3% | 0.18% | +149.3% |
| Q1 2014 | $1,077,000 | +21.3% | 41,586 | +20.6% | 0.07% | +69.0% |
| Q4 2013 | $888,000 | +0.5% | 34,469 | +4.4% | 0.04% | +5.0% |
| Q3 2013 | $884,000 | +296.4% | 33,029 | +263.5% | 0.04% | +344.4% |
| Q2 2013 | $223,000 | – | 9,086 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |